A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : FOP / Fibrodysplasia ossificans progressiva

[Related PubMed/MEDLINE]
Total Number of Papers: 360
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   FOP  (>> Co-occurring Abbreviation)
Long Form:   Fibrodysplasia ossificans progressiva
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2020 ALK2: A Therapeutic Target for Fibrodysplasia Ossificans Progressiva and Diffuse Intrinsic Pontine Glioma. ALK2, BMP, DIPG
2020 Analysis of clinical manifestations and treatment in 26 children with fibrodysplasia ossificans progressiva in China. ---
2020 Fibrodysplasia ossificans progressiva as a form of pseudodystonia. ---
2020 Fibrodysplasia ossificans progressiva-a rare disease with distinctive features yet still a diagnostic challenge: A case report. ACVR1
2020 Fibrodysplasia ossificans progressiva: Review and research activities in Japan. HO
2020 Radiotherapy in Fibrodysplasia Ossificans Progressiva: A Case Report and Systematic Review of the Literature. BCC, HO
2020 Self-reported baseline phenotypes from the International Fibrodysplasia Ossificans Progressiva (FOP) Association Global Registry. HO, IFOPA, PROMIS
2020 Serum osteocalcin level is associated with the mortality in Chinese patients with Fibrodysplasia ossificans progressiva aged ≤18 years at diagnosis. ---
2020 Skeletal malformations and developmental arthropathy in individuals who have fibrodysplasia ossificans progressiva. BMP, CT, HO
10  2020 Successful Airway and Anesthesia Management Using a High-Flow Nasal Cannula in a Fibrodysplasia Ossificans Progressiva Patient During General Anesthesia: A Case Report. HFNC
11  2020 Surgical management of bilateral hip fractures in a patient with fibrodysplasia ossificans progressiva treated with the RAR-gamma agonist palovarotene: a case report. HO
12  2019 Activation of Gq signaling by Pasteurella multocida toxin inhibits the osteoblastogenic-like actions of Activin A in C2C12 myoblasts, a cell model of fibrodysplasia ossificans progressiva. ALP, BMP, PMT
13  2019 ACVR1 Function in Health and Disease. DIPG
14  2019 An Adult Zebrafish Model of Fibrodysplasia Ossificans Progressiva. HO
15  2019 Application of in vitro Drug Metabolism Studies in Chemical Structure Optimization for the Treatment of Fibrodysplasia Ossificans Progressiva (FOP). ---
16  2019 Bilateral fibrodysplasia ossificans affecting the masticatory muscles and causing irreversible trismus in a domestic shorthair cat. vmROM
17  2019 Bis-Heteroaryl Pyrazoles: Identification of Orally Bioavailable Inhibitors of Activin Receptor-Like Kinase-2 (R206H). ALK2, DIPG
18  2019 BMP-dependent, injury-induced stem cell niche as a mechanism of heterotopic ossification. DTA, Hh, HO, MSC, MSCs
19  2019 Challenges in the treatment of fibrodysplasia ossificans progressiva. ---
20  2019 Development of Macrocycle Kinase Inhibitors for ALK2 Using Fibrodysplasia Ossificans Progressiva-Derived Endothelial Cells. BMP, ECFCs, HO
21  2019 Differential Vascularity in Genetic and Nonhereditary Heterotopic Ossification. BV, NHO, POH
22  2019 Elevated BMP and Mechanical Signaling Through YAP1/RhoA Poises FOP Mesenchymal Progenitors for Osteogenesis. BMP, HO, MEFs
23  2019 Elevated plasma RANTES in fibrodysplasia ossificans progressiva - A novel therapeutic target? CCL5, hMSCs, HO, RANTES
24  2019 Evolution of heterotopic bone in fibrodysplasia ossificans progressiva: An [18F]NaF PET/CT study. HO, SUV
25  2019 Fibrodysplasia Ossificans Progressiva (FOP): A Segmental Progeroid Syndrome. BMP
26  2019 Fibrodysplasia ossificans progressiva - can we diagnose it right at the outset? ---
27  2019 Fibrodysplasia ossificans progressiva: lessons learned from a rare disease. ACVR1
28  2019 Fibrodysplasia ossificans progressiva: lessons learned from a rare disease. ACVR1
29  2019 Generation of Fibrodysplasia ossificans progressiva and control integration free iPSC lines from periodontal ligament fibroblasts. ALK, BMP, iPSC
30  2019 Heterotopic Ossification in Mouse Models of Fibrodysplasia Ossificans Progressiva. HO
31  2019 Identification of the Identical Human Mutation in ACVR1 in 2 Cats With Fibrodysplasia Ossificans Progressiva. ---
32  2019 Inhibition of phosphatidylinositol 3-kinase alpha (PI3Kalpha) prevents heterotopic ossification. HO, PI3Kalpha
33  2019 Insights into the biology of fibrodysplasia ossificans progressiva using patient-derived induced pluripotent stem cells. iPSC
34  2019 Is fibrodysplasia ossificans progressiva an interleukin-1 driven auto-inflammatory syndrome? IL-1beta
35  2019 Late-onset fibrodysplasia ossificans progressiva with atypical presentation: A case report. ---
36  2019 Limb specific Acvr1-knockout during embryogenesis in mice exhibits great toe malformation as seen in Fibrodysplasia Ossificans Progressiva (FOP). ---
37  2019 Longitudinal Evaluation of Pain, Flare-Up, and Emotional Health in Fibrodysplasia Ossificans Progressiva: Analyses of the International FOP Registry. HO
38  2019 Molecular characterization of known and novel ACVR1 variants in phenotypes of aberrant ossification. DISH
39  2019 Natural history of fibrodysplasia ossificans progressiva: cross-sectional analysis of annotated baseline phenotypes. CAJIS, FOP-PFQ, HO
40  2019 Propranolol and ascorbic acid in control of fibrodysplasia ossificans progressiva flare-ups due to accidental falls. ---
41  2019 Simulation-Guided Tracheotomy in a Patient With Fibrodysplasia Ossificans Progressiva. ---
42  2019 Special considerations for clinical trials in fibrodysplasia ossificans progressiva (FOP). HO, ICC
43  2019 The effect of Activin-A on periodontal ligament fibroblasts-mediated osteoclast formation in healthy donors and in patients with fibrodysplasia ossificans progressiva. ACVR1, DC-STAMP, FKBP12, HO, ID-1, M-CSF, PLF, pSMAD3, RANK-L
44  2019 The role of Activin A in fibrodysplasia ossificans progressiva: a prominent mediator. ALK2, BMP, HO
45  2019 Therapeutic advances for blocking heterotopic ossification in fibrodysplasia ossificans progressiva. ---
46  2019 Two cases of myositis ossificans in children, after prolonged immobilization. MO, MOT
47  2019 [Fibrodysplasia ossificans progressiva. Report of one case]. ---
48  2018 A case report of mesenteric heterotopic ossification: Histopathologic and genetic findings. MHO, POH
49  2018 Activin A amplifies dysregulated BMP signaling and induces chondro-osseous differentiation of primary connective tissue progenitor cells in patients with fibrodysplasia ossificans progressiva (FOP). ActA, BMP, HO, SHED
50  2018 Activin-dependent signaling in fibro/adipogenic progenitors causes fibrodysplasia ossificans progressiva. BMP, FAPs, HO
51  2018 Acute and chronic rapamycin use in patients with Fibrodysplasia Ossificans Progressiva: A report of two cases. mTORC1
52  2018 Acute unilateral hip pain in fibrodysplasia ossificans progressiva (FOP). HO
53  2018 An mTOR Signaling Modulator Suppressed Heterotopic Ossification ofFibrodysplasia Ossificans Progressiva. FOP-ACVR1, FOP-iPSCs, HO, HTS
54  2018 An Overview of Recent Advances and Clinical Applications of Exon Skipping and Splice Modulation for Muscular Dystrophy and Various Genetic Diseases. AON, CRISPR, DMAT, DMD, FCMD, FDA, LGMD2B, MDC1A, MM
55  2018 Application of human induced pluripotent stem cells to model fibrodysplasia ossificans progressiva. BMP, hiPSCs
56  2018 Atypical Presentation of Fibrodysplasia Ossificans Progressiva: A Case Report and Review of Literature. ---
57  2018 Bone Resection Osteotomy in Fibrodysplasia Ossificans Progressiva. ---
58  2018 Cartilage-derived retinoic acid-sensitive protein (CD-RAP): A stage-specific biomarker of heterotopic endochondral ossification (HEO) in fibrodysplasia ossificans progressiva (FOP). CD-RAP, HEO, RARgamma
59  2018 Clinical staging of Fibrodysplasia Ossificans Progressiva (FOP). ADLs, CAJIS, HO
60  2018 Clinical-pathological correlations in three patients with fibrodysplasia ossificans progressiva. ---
61  2018 Depletion of Mast Cells and Macrophages Impairs Heterotopic Ossification in an Acvr1R206H Mouse Model of Fibrodysplasia Ossificans Progressiva. BMP, HO
62  2018 Difficult diagnosis and genetic analysis of fibrodysplasia ossificans progressiva: a case report. ---
63  2018 Drosophila models of FOP provide mechanistic insight. HO
64  2018 Early clinical observations on the use of imatinib mesylate in FOP: A report of seven cases. CML, HO
65  2018 ECSIT links TLR and BMP signaling in FOP connective tissue progenitor cells. BMP, CTPCs, ECSIT, TLR
66  2018 Effects of FKBP12 and type II BMP receptors on signal transduction by ALK2 activating mutations associated with genetic disorders. BMPs, DIPG
67  2018 Fibrodysplasia ossificans progressiva in China. ---
68  2018 Fibrodysplasia ossificans progressiva: The patient voice. ---
69  2018 Fibroplasia Ossificans Progressiva: A Case Report of a Rare Disease Entity. HO
70  2018 Flare-Up After Maxillofacial Surgery in a Patient With Fibrodysplasia Ossificans Progressiva: An [18F]-NaF PET/CT Study and a Systematic Review. HO, PET/CT, QOL
71  2018 Heterotopic bone induction via BMP signaling: Potential therapeutic targets for fibrodysplasia ossificans progressiva. BMP, TGF-beta
72  2018 Hints on transcriptional control of essential players in heterotopic ossification of Fibrodysplasia Ossificans Progressiva. BMP
73  2018 Hypoxia-selective allosteric destabilization of activin receptor-like kinases: A potential therapeutic avenue for prophylaxis of heterotopic ossification. BMP, HO
74  2018 Identification of small molecule inhibitors of ALK2: a virtual screening, density functional theory, and molecular dynamics simulations study. ALKs, BMPR, BMPs
75  2018 Imaging assessment of fibrodysplasia ossificans progressiva: Qualitative, quantitative and questionable. CT, HO
76  2018 Injury of Adult Zebrafish Expressing Acvr1lQ204D Does Not Result in Heterotopic Ossification. CTX, HO
77  2018 Joint-specific risk of impaired function in fibrodysplasia ossificans progressiva (FOP). ---
78  2018 Longitudinal patient-reported mobility assessment in fibrodysplasia ossificans progressiva (FOP). CAJIS, PRMA
79  2018 Mast cell inhibition as a therapeutic approach in fibrodysplasia ossificans progressiva (FOP). ---
80  2018 Modeling human somite development and fibrodysplasia ossificans progressiva with induced pluripotent stem cells. iPSCs, MYO, SCL, SMs, SYN
81  2018 Morpholino-Mediated Exon Skipping Targeting Human ACVR1/ALK2 for Fibrodysplasia Ossificans Progressiva. BMP, PMOs
82  2018 NF-kappaB/MAPK activation underlies ACVR1-mediated inflammation in human heterotopic ossification. BMPs, TAK1
83  2018 Palovarotene Inhibits Osteochondroma Formation in a Mouse Model of Multiple Hereditary Exostoses. BMP, HS, MHE, MO, PVO
84  2018 Palovarotene reduces heterotopic ossification in juvenile FOP mice but exhibits pronounced skeletal toxicity. FAPs, HO
85  2018 Periodontal ligament fibroblasts as a cell model to study osteogenesis and osteoclastogenesis in fibrodysplasia ossificans progressiva. ALP, BMPR-1, PLF
86  2018 Peripheral Blood Mononuclear Cell Immunophenotyping in Fibrodysplasia Ossificans Progressiva Patients: Evidence for Monocyte DNAM1 Up-regulation. PBMC
87  2018 Prevalence and risk factors for kidney stones in fibrodysplasia ossificans progressiva. ---
88  2018 Recent Topics in Fibrodysplasia Ossificans Progressiva. ---
89  2018 Retinoid roles and action in skeletal development and growth provide the rationale for an ongoing heterotopic ossification prevention trial. BMP, HME, HO
90  2018 Shared ACVR1 mutations in FOP and DIPG: Opportunities and challenges in extending biological and clinical implications across rare diseases. BMP, DIPGs
91  2018 Stem cells and heterotopic ossification: Lessons from animal models. HO
92  2018 Structural basis for the potent and selective binding of LDN-212854 to the BMP receptor kinase ALK2. ---
93  2018 The FOP Connection Registry: Design of an international patient-sponsored registry for Fibrodysplasia Ossificans Progressiva. IFOPA
94  2018 The Horizon of a Therapy for Rare Genetic Diseases: A "Druggable" Future for Fibrodysplasia Ossificans Progressiva. BMPs, GS
95  2018 The obligatory role of Activin A in the formation of heterotopic bone in Fibrodysplasia Ossificans Progressiva. HO
96  2018 Unresolving trismus following third molar surgery: Report of a case of fibrodysplasia ossificans progressiva with review of literature. ---
97  2018 Variable signaling activity by FOP ACVR1 mutations. ---
98  2018 Variant BMP receptor mutations causing fibrodysplasia ossificans progressiva (FOP) in humans show BMP ligand-independent receptor activation in zebrafish. ---
99  2018 [18F]NaF PET/CT scan as an early marker of heterotopic ossification in fibrodysplasia ossificans progressiva. HO
100  2017 A cumulative analogue joint involvement scale (CAJIS) for fibrodysplasia ossificans progressiva (FOP). CAJIS, HO